Solaris Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Solaris Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-370	Closed	-$13K	–	285
2016 Q4	$13K	Hold	370	–	–	0.01%	215
2016 Q3	$17K	Buy	+370	New	+$19.3K	0.01%	248
2016 Q2	–	Sell	-100	Closed	-$5K	–	216
2016 Q1	$5K	Buy	100 +77	+335%	+$4.52K	﹤0.01%	181
2015 Q4	$2K	Hold	23	–	–	﹤0.01%	180
2015 Q3	$1K	Buy	+23	New	+$1.49K	﹤0.01%	172

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Solaris Asset Management's TEVA Position: Q1 2017 in Review

Solaris Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2017, closing a stake of 370 shares — an estimated $13K sold.

Solaris Asset Management first reported a position in TEVA in Q3 2015 and held it in 5 quarters. The position peaked at $17K in Q3 2016. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

Solaris Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2017 after selling out during the quarter.
Solaris Asset Management sold 370 Teva Pharmaceutical Industries Limited shares in Q1 2017, an estimated $13K.
Solaris Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2015 and held it in 5 quarters.
Solaris Asset Management's Teva Pharmaceutical Industries Limited position peaked at $17K in Q3 2016.
688 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2017.

Based on Solaris Asset Management's 13F filing for Q1 2017, filed 3 May 2017.